IO Biotech/$IOBT
About IO Biotech
Ticker
Industry
Headquarters
Employees
IO Biotech Metrics
$57M
-
-$1.37
0.27
-
Price and volume
Market cap
$57M
Beta
0.27
52-week high
$1.95
52-week low
$0.66
Average daily volume
279K
Financial strength
Current ratio
5.372
Quick ratio
4.994
Long term debt to equity
1.826
Total debt to equity
2.782
Management effectiveness
Return on assets (TTM)
-45.91%
Return on equity (TTM)
-78.50%
Valuation
Price to book
0.78
Price to tangible book (TTM)
0.78
Price to free cash flow (TTM)
-0.664
Growth
Earnings per share change (TTM)
-41.39%
3-year earnings per share growth (CAGR)
-83.69%
What the Analysts think about IO Biotech
Analyst Ratings
IO Biotech Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
IO Biotech Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
IO Biotech News
IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer
IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank
IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights
FAQs
What’s the current market cap for IO Biotech stock?
What is the P/E ratio for IO Biotech stock?
Does IO Biotech stock pay dividends?
No, IO Biotech (IOBT) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next IO Biotech dividend payment date?
IO Biotech (IOBT) stock does not pay dividends to its shareholders.
What is the beta indicator for IO Biotech?
IO Biotech (IOBT) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.